chrX-37572039-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001170331.2(LANCL3):c.169G>A(p.Gly57Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000709 in 112,839 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001170331.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LANCL3 | NM_001170331.2 | c.169G>A | p.Gly57Arg | missense_variant | 1/5 | ENST00000378619.4 | |
LANCL3 | NM_198511.3 | c.169G>A | p.Gly57Arg | missense_variant | 1/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LANCL3 | ENST00000378619.4 | c.169G>A | p.Gly57Arg | missense_variant | 1/5 | 1 | NM_001170331.2 | P1 | |
LANCL3 | ENST00000378621.7 | c.169G>A | p.Gly57Arg | missense_variant | 1/6 | 1 | |||
LANCL3 | ENST00000614025.4 | c.169G>A | p.Gly57Arg | missense_variant | 1/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000709 AC: 8AN: 112839Hom.: 0 Cov.: 23 AF XY: 0.0000571 AC XY: 2AN XY: 35001
GnomAD3 exomes AF: 0.00000807 AC: 1AN: 123976Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 36632
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000468 AC: 50AN: 1067272Hom.: 0 Cov.: 29 AF XY: 0.0000465 AC XY: 16AN XY: 344064
GnomAD4 genome AF: 0.0000709 AC: 8AN: 112839Hom.: 0 Cov.: 23 AF XY: 0.0000571 AC XY: 2AN XY: 35001
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2024 | The c.169G>A (p.G57R) alteration is located in exon 1 (coding exon 1) of the LANCL3 gene. This alteration results from a G to A substitution at nucleotide position 169, causing the glycine (G) at amino acid position 57 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at